Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

The Pharmaceutical Application Term Sheet Provides Enveric Biosciences Could Be Eligible To Receive Future Development And Sales Milestone Payments That In Total Could Add Up To Approximately $61M

Author: Benzinga Newsdesk | March 19, 2024 07:08am

Royalty rates could range from 2.5% up to 10% on future sales, depending on meeting certain sales criteria.

Posted In: ENVB